See also this year's filing and all EDGAR filings for this company.
PDF Report 0001513525_2025_Adial_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001513525, Adial Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,058,764 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,348 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 981,830 |
| 4 | LiabilitiesCurrent | 975,858 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,203,158 |
| 9 | ResearchAndDevelopmentExpense | 3,184,293 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,749,714 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,043,942 |
| 1 | Liabilities | 975,858 |
| 2 | Expenses | 8,387,451 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 4,068,084 |
| 5 | NetIncome | -10,137,165 |
| 6 | ComprehensiveNetIncome | -10,137,165 |
| 7 | BaseVar | 8,078,482 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.422 |
| 9 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
